Jan 14 (Reuters) - AbbVie said on Wednesday it is seeking to expand its presence in the fast-growing market ​for obesity treatments, leaning on the weight-loss drug it licensed ‌last year from Danish biotech Gubra. Gubra's drug, GUBamy, mimics the hormone amylin and could ‌be used as an alternative to popular GLP-1 drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound to help people lose more weight with fewer side effects.

The FDA upgraded the earlier cheese recall to a Class I designation.

NEW YORK, Jan 14 (Reuters) - U.S. healthcare spending rose by 7.2% to $5.3 trillion in 2024 from $4.9 trillion in 2023, driven by increased health insurance enrollment and a jump in use of medical

Jan 13 () - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help ​accelerate drug discovery through artificial intelligence. The company said ‌it was partnering with drugmakers AstraZeneca, Merck and Eli Lilly for its Billion ‌Cell Atlas, which will train advanced AI models at scale and advance research into fundamental disease mechanisms that have previously been out of reach.

SAN FRANCISCO, Jan 13 () - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry ​increases its use of artificial intelligence to accelerate the discovery of ‌new drugs. The companies did not disclose financial terms.

By Sneha S K and Gnaneshwar Rajan Jan 13 (Reuters) - Thermo Fisher Scientific's pharmaceutical services business has won a ​number of contracts to help its customers move production ‌from Europe or Asia to the U., the medical equipment maker's CEO, ‌Marc Casper, said on Tuesday.

Here's how to lock in Paramount+'s current pricing before they raise their rates.

March arabica coffee (KCH26 ) on Tuesday closed up +4.20 (+1.18%). March ICE robusta coffee (RMH26 ) closed up +36 (+0.92%). Coffee prices settled higher on Tuesday amid concerns that excessive dryness in Brazil could lead to smaller coffee yields. Last Thursday, arabica rallied to a 1-month high due to...

Jan 12 () - Novartis will continue to do bolt-on deals and its capital allocation priorities remain unchanged, CEO Vasant ​Narasimhan said at a major industry conference that kicked ‌off on Monday in San Francisco. "We are always looking for opportunities that fit ‌our core therapeutic areas," Narasimhan said at the J.

Jan 12 (Reuters) - Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial ​insurance plans, the drugmaker's CEO Daniel O'Day said at ‌a major industry conference that kicked off on Monday in San Francisco. "CVS has ‌confirmed their coverage of Yeztugo as of January 1, putting us at more than 80% (insurer) coverage overall," O'Day said.

Jan 12 () - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at ​a major industry conference that kicked off on Monday in San Francisco. The ‌medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly ‌in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market.

Mattel announced a new Barbie doll, the first with autism, on Sunday.

The head of the nation's most important financial institution has been the target of relentless criticism from President Trump.

Jan 12 () - Revvity said on Monday it expects ​its 2025 adjusted profit per ‌share to exceed its forecast of $4.90 ‌to $5, as the medical equipment maker benefits from renewed demand for contract research and diagnostics ⁠services.

Jan 9 (Reuters) - The U.S.

Jan 6 (Reuters) - Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court ​on Tuesday for allegedly misusing its messenger RNA technology ‌in manufacturing their vaccines, a Bayer spokesperson confirmed. The patent infringement lawsuits said the companies ‌copied technology developed by Monsanto in the 1980s for strengthening mRNA in crops in order to stabilize the genetic material used in their vaccines.

NEW YORK, Dec 31 (Reuters) - Drugmakers plan to raise U. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration pressures them for cuts, according to data provided exclusively ​by healthcare research firm 3 Axis Advisors.

By Sneha S K and Sahil Pandey Dec 31 (Reuters) - The U. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the ​treatment of a rare hormonal disorder, the company said on Wednesday.

March ICE NY cocoa (CCH26 ) today is down -178 (-2.93%). March ICE London cocoa #7 (CAH26 ) is down -129 (-2.95%). Cocoa prices are sharply lower today, posting 1-week lows. Improved weather in West Africa is weighing on cocoa prices today. Tropical General Investments Group said today that favorable...

Business Insider reached out to more than 75 major employers, including Walmart and Google, about their efforts to support aging workers.

A 1982 Lotus Esprit Turbo that has spent three decades sitting untouched in a barn is set to cross the auction block in the United Kingdom, offering collectors a rare look at long-term automotive neglect wrapped in iconic sports car design. The car, now coated in moss and other organic growth, has been entered into a classic and vintage vehicle auction held at the Haynes Motor Museum. The sale is being organized by Charterhouse, a Dorset-based auction house known for handling estate and specialt

NEW YORK, Dec 31 (Reuters) - Drugmakers plan to raise U. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration pressures them for cuts, according to data provided exclusively ​by healthcare research firm 3 Axis Advisors.

SpaceX just set a new annual-launch record for the sixth year in a row, and the numbers are getting pretty silly.

US electric car manufacturer Tesla is aiming to increase in production at its factory in Grünheide near Berlin in 2026, despite the difficult market situation in Germany. Output already grew in each quarter of the past year as planned, plant manager André Thierig told dpa in a recent interview.

The European continent is teeming with EVs, and it’s never been easier to own and charge one. But everything is under China's shadow.

Tory Bruno, the longtime chief of the launch provider United Launch Alliance (ULA) has joined the competition at Blue Origin.

We saw quite a few milestones notched in the final frontier this year. But there were a number of failures as well, some of them quite dramatic.

LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming video membership; dose decisions managed on a smartphone app; access made as easy as buying a pair of Nikes. This is their vision of the consumerization of weight-loss as drugmakers Novo Nordisk and Eli Lilly prepare to launch pill versions alongside their blockbuster injectable treatments and incr

Adam Raine’s life hurtled toward tragedy soon after he began talking with ChatGPT about homework last fall. Their exchanges grew more consuming as the 16-year-old opened up to the chatbot about his suicidal thoughts, according to data analysis of the conversations shared with The Washington Post by attorneys for Adam’s parents.Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. In January, the high school sophomore spent just under an ho

More than half of Germany's medium-sized companies expect an economic downturn next year, according to a survey by the BVMW business association. Christoph Ahlhaus, the association's chief executive, said on Saturday that "superficial reforms are no longer enough to get Germany back on track.